Garcia-Knight, MA, Nduati, E, Hassan, AS, Nkumama, i, Etyang, TJ, Gambo, F, Odera, D, Berkley, JA, Rowland-Jones, SL, Urban, Britta ORCID: https://orcid.org/0000-0002-4197-8393 and Hajj, NJ (2017) 'Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants'. AIDS, Vol 31, Issue 13, pp. 1809-1818.
|
Text
Aids_June_2017_Cytomegalovirus viraemia.pdf - Accepted Version Available under License Creative Commons Attribution. Download (450kB) | Preview |
Abstract
Objective: Factors associated with poor health in HIV-exposed-uninfected (HEU) infants are poorly defined. We describe the prevalence and correlates of CMV viraemia in HEU and HIV-unexposed-uninfected (HUU) infants, and quantify associations with anthropometric, haematological and immunological outcomes.
Design: Cross-sectional, including HEU and HUU infants from rural coastal Kenya.
Methods: Infants aged 2-8 months were studied. The primary outcome was CMV viraemia and viral load, determined by quantitative PCR. Correlates were tested by logistic and linear regression; coefficients were used to describe associations between CMV viraemia and clinical/immunological parameters.
Results: 42/65 (64.6%) infants had CMV viraemia (median viral load, 3.0 [IQR: 2.7-3.5] log10 IU/mL). Compared to community controls, HEU infants had 6-fold increased odds of being viraemic (adjusted OR 5.95 [95% CI: 1.82-19.36], P=0.003). Age, but not HEU/HUU status, was a strong correlate of CMV viral load (coeff = -0.15, P = 0.009). CMV viral load associated negatively with weight-for-age z-score (coeff. = -1.06, P = 0.008) and head circumference-for-age z-score (coeff. = -1.47, P = 0.012) and positively with CD8 T cell co-expression of CD38/HLADR (coeff. = 15.05, P = 0.003).
Conclusions: The odds of having CMV viraemia was six-fold greater in HEU than HUU infants when adjusted for age. CMV viral load was associated with adverse growth and heightened CD8 T cell immune activation. Longitudinal assessments of the clinical effects of primary CMV infection and associated immunomodulation in early life in HEU and HUU populations are warranted.
Statistics
Actions (login required)
Edit Item |